Legacy Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Buy
844
+148
+21% +$151K 0.44% 34
2026
Q1
$640K Buy
696
+100
+17% +$101K 0.33% 39
2025
Q4
$641K Buy
+596
New +$570K 0.42% 34

Other funds holding LLY

Legacy Wealth Advisors's LLY Position: Q2 2026 in Review

Legacy Wealth Advisors increased its Eli Lilly (LLY) stake by 21% in Q2 2026, buying an estimated $151K and bringing the position to 844 shares worth $1.01M. The position accounts for 0.44% of the portfolio, ranked #34.

Legacy Wealth Advisors first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Legacy Wealth Advisors held 844 shares of Eli Lilly worth $1.01M as of Q2 2026.
  • Legacy Wealth Advisors bought 148 Eli Lilly shares in Q2 2026, an estimated $151K.
  • Eli Lilly made up 0.44% of Legacy Wealth Advisors's portfolio in Q2 2026, its #34 holding.
  • Legacy Wealth Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Legacy Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.